Almac Group Announces Successful MHRA Inspection at Charnwood FacilitiesCraigavon, N.I., UK, 23 October 2017 – Almac Group, the Craigavon based global contract pharmaceutical development and manufacturing organisation, is pleased to announce the successful inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new Pharmaceutical Development & Manufacturing facilities at Charnwood Campus, Loughborough.
In November 2015, to meet ongoing client demand, Almac Group announced the expansion of its pharmaceutical development & manufacturing services with the acquisition of a significant proportion of the 70-acre Charnwood Campus in Loughborough, England – a world-class science, technology and enterprise park. Since that announcement, the facilities have undergone significant investment both in building enhancements and the installation and validation of new processing and analytical technology.





Irish Chamber member, Joe Burke (far right) pictured here with fellow member, Paul Maguire (far left), Gene Barr, President & CEO of
Almac Pod™ – Changing the Global Dynamics of Temperature Controlled Shipping Solutions